A successful transcatheter aortic valve implantation in an extremely tortuous s-shaped aorta due to chest deformation

Aleksandra Gąsecka, Katarzyna Solarska, Bartłomiej Rydz, Iga Ślesicka, Bartosz Rymuza, Zenon Huczek, Janusz Kochman

Research output: Contribution to journalComment/Letter to the editorAcademic


A 65-year-old woman was admitted to the hospital for interventional treatment of aortic stenosis. Echocardiography confirmed severe aortic stenosis and a normal left ventricular ejection fraction (60%). Computed tomography demonstrated an extremely tortuous, S-shaped descending aorta and a significant scoliosis with chest wall deformation (Figs. 1A, B). Considering the complex anatomy, the Heart Team qualified the patient for transcatheter aortic valve implantation (TAVI), despite the low peri-operative risk (1.54% in the EuroScore II). Transcatheter aortic valve implantation was performed in a standard manner, under local anesthesia, from the right femoral artery. Once the Confida Brecker Curve guidewire was placed in the aortic arch, the valve was predilated with 20 mm balloon. A 26 mm Evolut PRO valve (Medtronic Inc., Minneapolis, Minnesota) was slowly advanced into the aorta, which was techni cally challenging (Fig. 1C, Suppl. Video 1). The valve was correctly aligned and deployed under rapid pacing (120/min). Aortogram at the end of the procedure showed no evidence of aortic injury or paravalvular leak (Fig. 1D). Procedural success was confirmed by control transthoracic echocardiography. The indications for transfemoral TAVI are expanding. The final decision considering the type of procedure should be made by the Heart Team, based on an individual’s evaluation. Despite the low risk of mortality following surgery, the patient suffered from the extreme chest wall deformation which made successful sternotomy and latter rehabilitation improbable. Given the flexibility of second generation TAVI delivery systems, it is possible to safely perform the procedure even in a severely tortuous anatomy, which was initially considered a contraindication for TAVI.
Original languageEnglish
Pages (from-to)790-791
Number of pages2
JournalCardiology journal
Issue number5
Publication statusPublished - 3 Sep 2021

Cite this